We studied the alterations in myocardial
beta-adrenergic receptor-
adenylate cyclase activity and
muscarinic receptor density in a canine model of left ventricular (LV) failure. LV failure was characterized by a doubling of LV
weight/body weight ratio (3.3 +/- 0.1 to 6.9 +/- 0.4 g/kg) and an elevation of LV end-diastolic pressure, 32 +/- 4.5 mmHg, compared with 7.7 +/- 0.6 mmHg in normal dogs. Despite a 44% increase in receptor density as measured by antagonist binding studies with [3H]
dihydroalprenolol, there was a twofold decrease in receptor affinity, i.e., an increase in the dissociation constant (Kd) (5.6 +/- 0.7 to 12 +/- 1.6 nM) in
heart failure. Agonist displacement of [3H]
dihydroalprenolol binding with
isoproterenol in the presence and absence of 5'-guanylylimidodiphosphate [
Gpp(NH)p] demonstrated a striking loss of high affinity binding sites in
heart failure (51 +/- 16 to 11 +/- 5%).
Beta-Adrenergic receptor-mediated stimulation of
adenylate cyclase and maximal stimulation with
Gpp(NH)p or
sodium fluoride was reduced in
heart failure. There was a concomitant marked, P less than 0.01, reduction in
muscarinic receptor density (242 +/- 19 vs. 111 +/- 20 fmol/mg). Thus, while
muscarinic receptor density fell,
beta-adrenergic receptor density actually increased in LV failure. However, a larger portion of the
beta-adrenergic receptors are not functionally coupled to the
GTP-stimulatory
protein (Ns), as evidenced by a decrease in the fraction of receptors that bind agonist with high affinity.